Genus (LON:GNS) Share Price Passes Above 200 Day Moving Average - Here's What Happened

Key Points

• Technical breakout: Genus shares crossed above their 200‑day moving average, trading as high as GBX 2,720 and last at GBX 2,658 versus the 200‑day MA of GBX 2,655.84 on volume of 2,204,632 shares.
• Analyst sentiment is positive: Three analysts rate GNS a "Buy" with a consensus target of GBX 3,216.67 (Deutsche Bank raised its target to GBX 3,300 and Berenberg set GBX 3,350).
• Valuation and insider activity: The company has a market cap of £1.77bn and a P/E of 37.44, and insider Celia Baxter purchased 1,728 shares at GBX 2,893; insiders own 0.70% of the stock.

Genus plc (LON:GNS - Get Free Report)'s share price crossed above its two hundred day moving average during trading on Thursday . The stock has a two hundred day moving average of GBX 2,655.84 and traded as high as GBX 2,720. Genus shares last traded at GBX 2,658, with a volume of 2,204,632 shares trading hands.

Analyst Ratings Changes

A number of research firms recently weighed in on GNS. Shore Capital Group reaffirmed a "buy" rating and issued a GBX 3,000 price objective on shares of Genus in a research note on Friday, January 16th. Deutsche Bank Aktiengesellschaft raised their target price on shares of Genus from GBX 3,100 to GBX 3,300 and gave the company a "buy" rating in a research report on Friday, January 16th. Finally, Berenberg Bank restated a "buy" rating and issued a GBX 3,350 price target on shares of Genus in a report on Wednesday, April 1st. Three analysts have rated the stock with a Buy rating, According to data from MarketBeat, the company currently has a consensus rating of "Buy" and a consensus target price of GBX 3,216.67.

Genus Price Performance

The stock has a fifty day moving average price of GBX 2,755.01 and a 200-day moving average price of GBX 2,655.84. The firm has a market capitalization of £1.77 billion, a PE ratio of 37.44, a P/E/G ratio of 2.87 and a beta of 0.94. The company has a debt-to-equity ratio of 55.10, a quick ratio of 1.08 and a current ratio of 2.25.

Genus (LON:GNS - Get Free Report) last issued its quarterly earnings data on Thursday, February 26th. The company reported GBX 60.80 earnings per share for the quarter. Genus had a return on equity of 9.70% and a net margin of 7.07%. Sell-side analysts forecast that Genus plc will post 70.9644323 EPS for the current fiscal year.

Insider Buying and Selling

In other news, insider Celia Baxter purchased 1,728 shares of the firm's stock in a transaction on Friday, February 27th. The stock was acquired at an average cost of GBX 2,893 per share, with a total value of £49,991.04. Corporate insiders own 0.70% of the company's stock.

Genus Company Profile

Genus plc operates as an animal genetics company in North America, Latin America, the United Kingdom, rest of Europe, the Middle East, Russia, Africa, and Asia. The company operates through three segments: Genus PIC, Genus ABS, and Genus Research and Development. It sells breeding pigs and semen to breed pigs with various characteristics for pork production under the PIC brand. The company also sells bull semen and embryos to breed calves with various characteristics for milk and beef production under the ABS, Genus, and Bovec brands.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.